NELFE and breast cancer: For instance, oncogenic activation of NELFE promotes hepatocellular carcinoma (HCC) cell proliferation and predicts the strong metastatic potential of HCC cells [12], whereas knockdown of NELFE results in enhanced cell colony growth of breast cancer cells when treated with estrogen-like reagents [13].